On the use of 2,5-dimethyl-pyrrol-1-yl-benzoic acid derivatives as EPH-ephrin antagonists

Journal of Virology

Volumn 88, Issue 20, 2014, Pages 12173-

  Lodola, Alessio ^a   Incerti, Matteo ^a   Tognolini, Massimiliano ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 DIMETHYLPYRROL 1 YLBENZOIC ACID DERIVATIVE; BENZOIC ACID DERIVATIVE; EPHRIN A4; EPHRIN A5; EPHRIN KINASE; EPHRIN RECEPTOR A2; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; EPHRIN; MOLECULAR LIBRARY; PROTEIN BINDING;

BINDING AFFINITY; CHEMICAL MODIFICATION; DRUG POTENCY; DRUG STRUCTURE; HUMAN; IC50; LETTER; OXIDATION; POLYMERIZATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; DRUG EFFECTS; HUMAN HERPESVIRUS 8; METABOLISM; MOLECULAR LIBRARY; PHARMACOLOGY;

EPHRINS; HERPESVIRUS 8, HUMAN; HUMANS; PROTEIN BINDING; RECEPTOR, EPHA2; SMALL MOLECULE LIBRARIES;

EID: 84907449155     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02152-14     Document Type: Letter

References (7)

1. Noberini R, Koolpe M, Peddibhotla S, Dahl R, Su Y, Cosford NDP, Roth GP, Pasquale EB. 2008. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors. J. Biol. Chem. 283:29461-29472. http://dx.doi.org/10.1074/jbc.M804103200.
2. Tournoij E, Koekman CA, Du VX, Roest M, Ruijtenbeek R, Moll FL, Akkerman JW. 2012. The platelet P2Y12 receptor contributes to granule secretion through Ephrin A4 receptor. Platelets 23:617-625. http://dx.doi.org/10.3109/09537104.2011.645924.
3. Van Hoecke A, Schoonaert L, Lemmens R, Timmers M, Staats KA, Laird AS, Peeters E, Philips T, Goris A, Dubois B, Andersen PM, Al-Chalabi A, Thijs V, Turnley AM, van Vught PW, Veldink JH, Hardiman O, Van Den Bosch L, Gonzalez-Perez P, Van Damme P, Brown RH, Jr, van den Berg LH, Robberecht W. 2012. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat. Med. 18:1418-1422. http://dx.doi.org/10.1038/nm.2901.
4. Hahn AS, Desrosiers RC. 2014. Binding of the Kaposi's sarcomaassociated herpesvirus to the ephrin binding surface of the EphA2 receptor and its inhibition by a small molecule. J. Virol. 88:8724-8734. http://dx.doi.org/10.1128/JVI.01392-14.
5. Baell JB, Holloway GA. 2010. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J. Med. Chem. 53:2719-2740. http://dx.doi.org/10.1021/jm901137j.
6. Noberini R, De SK, Zhang Z, Wu B, Raveendra-Panickar D, Chen V, Vazquez J, Qin H, Song J, Cosford ND, Pellecchia M, Pasquale EB. 2011. A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors. Chem. Biol. Drug Des. 78:667-678. http://dx.doi.org/10.1111/j.1747-0285.2011.01199.x.
7. Zhu W, Groh M, Haupenthal J, Hartmann RW. 2013. A detective story in drug discovery: elucidation of a screening artifact reveals polymeric carboxylic acids as potent inhibitors of RNA polymerase. Chem. Eur. J. 19:8397-8400. http://dx.doi.org/10.1002/chem.201301289.